Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Filings indexed 641 across all filing types
Latest filing 2016-08-18 Director's Dealing
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2016-08-18 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-17 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 16, 2016. It reports amendments to the Articles of Incorporation and Bylaws in connection with the closing of the company's initial public offering. The document includes exhibits of the amended and restated certificate of incorporation and bylaws. There are no financial statements or detailed financial data presented, nor is this a full annual or quarterly report. The content focuses on corporate governance changes related to incorporation documents and bylaws, which aligns with announcements about board or management structural changes or governance documents. However, since the changes pertain to the certificate of incorporation and bylaws, this is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit the more specific categories like MANG (board/management changes) or CGR (governance information report). The document length is under 5,000 characters and is a standalone filing, not an announcement of a report publication. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2016-08-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.